KYIV, Ukraine--(BUSINESS WIRE)--Darnitsa Pharmaceuticals, one of Ukraine’s largest pharmaceutical producers, through its holding company Nord Star Pharmashare (Denmark) has successfully placed a 10% equity stake among foreign investors for USD 48 m, giving Darnitsa a total MCap of USD 560 m. Shares of Nord Star Pharmashare were sold in the form of global depositary receipts (GDR) issued by The Bank of New York and began trading on the Frankfurt stock exchange on October 5. The price per GDR corresponding to one share was USD 8.7 at the placement. In all, 5 555 550 depositary receipts were placed on the exchange.
